These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6229914)

  • 1. Effects of passive enhancement on graft and host. Graft adaptation by alloantibody as the mechanism of prolonged skin allograft survival.
    McCullough CS; Sugarbaker PH; Matthews W
    Transplantation; 1984 Jan; 37(1):91-6. PubMed ID: 6229914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abrogation of T cell homing by alloantibody.
    Chang AE; Sugarbaker PH
    Transplantation; 1980 Feb; 29(2):127-32. PubMed ID: 6986686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged skin allograft survival through enhancement effects on donor tissue.
    Deutsch HL; Edington HD; McCullough CM; Sugarbaker PH
    Transplantation; 1986 Aug; 42(2):200-4. PubMed ID: 3526658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
    de Waal RM; Capel PJ; Koene RA
    J Immunol; 1980 Feb; 124(2):719-23. PubMed ID: 6985936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of anti-skin allograft immunity induced by infusions with photoinactivated effector T lymphocytes--the congenic model.
    Perez MI; Berger CL; Yamane Y; John L; Laroche L; Edelson RL
    Transplantation; 1991 Jun; 51(6):1283-9. PubMed ID: 1828639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.
    Ildstad ST; Wren SM; Oh E; Hronakes ML
    Transplantation; 1991 Jun; 51(6):1262-7. PubMed ID: 1828637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential homing of passively transferred T cells into skin allografts of mice.
    Chang AE; Sugarbaker PH
    Transplantation; 1979 Sep; 28(3):247-52. PubMed ID: 40333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of histocompatibility barriers in congenic strains of mice. III. Passive enhancement of skin allografts in X-irradiated hosts.
    Cantrell JL; Kaliss N; Hildemann WH
    Transplantation; 1975 Feb; 19(2):95-101. PubMed ID: 1091043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological unresponsiveness induced by ultraviolet-B-irradiated and nonirradiated skin grafts.
    Vandekerckhove BA; Datema G; Claas FH
    Transplantation; 1990 Mar; 49(3):596-9. PubMed ID: 2316019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of alloantibodies on corneal allograft survival.
    Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperacute rejection of skin allografts in the mouse. Sensitivity of ingrowing skin grafts to the action of alloantibody and rabbit complement.
    Gerlag PG; Koene RA; Hagemann JF; Wijdeveld PG
    Transplantation; 1975 Oct; 20(4):308-13. PubMed ID: 1099736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal analysis of the lymphoid cells mediating skin allograft rejection. Mediation of graft rejection in vivo by cloned Lyt-1+2- proliferative, noncytotoxic long-term cell lines.
    Kim B; Rosenstein M; Weiland D; Eberlein TJ; Rosenberg SA
    Transplantation; 1983 Nov; 36(5):525-32. PubMed ID: 6356516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microheterogeneity in regulatory circuits for T-cell alloresponsiveness.
    Gorczynski RM; Macrae S
    Immunology; 1981 Dec; 44(4):827-46. PubMed ID: 6172375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms maintaining enhancement of allografts. I. Demonstration of a specific suppressor cell.
    Hall BM
    J Exp Med; 1985 Jan; 161(1):123-33. PubMed ID: 3155790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice.
    Ohzato H; Monaco AP
    Transplantation; 1992 Dec; 54(6):1090-5. PubMed ID: 1465774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ehancement and hyperacute rejection of skin grafts in the mousefailure to separate cytotoxic and enhancing antibodies from alloantiserum with physicochemical methods.
    Jansen JL; Koene RA; Kamp GJ; Gerlag PG; Wijdeveld PA
    J Immunol; 1975 May; 114(5):1557-62. PubMed ID: 804518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alloimmunization-activated suppressor cells. II. In vitro activity of suppressor cells implicated in the abrogation of lethal graft-versus-host reaction.
    Pritchard LL; Halle-Pannenko O
    Transplantation; 1983 Sep; 36(3):310-8. PubMed ID: 6225230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
    Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
    J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of neonatally and adoptively induced transplantation tolerance in mice.
    Hasek M; Holán V; Chutná J
    Folia Biol (Praha); 1980; 26(3):167-75. PubMed ID: 6448173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.